Shiguang Chen

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma.

|Apr 02, 2026
Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study.

Xiaolong Wang, Qinggui Jiang, Shiguang Chen

|Mar 16, 2026
A Retrospective Study of Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Hepatocellular Carcinoma Patients with Main Portal Vein Tumor Thrombus (VP4).

Xiaolong Wang, Shiguang Chen, Wenchang Yu

|Jul 20, 2022
Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score-matching cohort study.

Shiguang Chen, Bo Yuan, Wenchang Yu

|Jan 19, 2021
Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug-eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma.

Shiguang Chen, Wenchang Yu, Kongzhi Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Xiaolong Wang

2 joint publications

Wenchang Yu

2 joint publications

Weifu Liu

2 joint publications

Zhuting Fang